RespireRx Pharmaceuticals Inc. (RSPI)

RespireRx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0.01	0	0	0	0.02	0.03
Cash & Cash Equivalents	0.01	0	0	0	0.02	0.03
Cash Growth	10503.33%	-93.71%	69.45%	-95.06%	-49.86%	-60.80%
Other Current Assets	0.1	0.02	0.21	0.08	0.03	0.09
Total Current Assets	0.11	0.02	0.21	0.09	0.05	0.12
Other Long-Term Assets	0.01	0	0.18	0.05	0	0
Total Long-Term Assets	0.01	0	0.18	0.05	0	0
Total Assets	0.11	0.02	0.21	0.09	0.05	0.12
Accounts Payable	0	5.72	5.24	4.92	3.77	0
Deferred Revenue	-0	-5.72	-5.24	-4.92	-3.77	-0
Current Debt	2.21	2.71	2.08	1.68	1.63	1.25
Other Current Liabilities	9.85	9.02	7.84	6.46	5.86	4.61
Total Current Liabilities	12.06	11.73	9.92	8.15	7.49	5.86
Other Long-Term Liabilities	0.34	0.17	0.29	0	0	1.25
Total Long-Term Liabilities	0.34	0.17	0.29	0	0	1.25
Total Liabilities	12.41	11.9	10.22	8.15	7.49	5.86
Total Debt	2.21	2.71	2.08	1.68	1.63	1.25
Debt Growth	-13.36%	30.35%	23.42%	3.02%	30.75%	8.80%
Common Stock	0.02	0.13	0.1	0.07	0	0
Retained Earnings	-177.56	-176.06	-173.96	-170.81	-166.51	-164.39
Comprehensive Income	-0.17	-0	0	0	0	0
Shareholders' Equity	-12.3	-11.88	-10.01	-8.06	-7.44	-5.73
Total Liabilities and Equity	0.11	0.02	0.21	0.09	0.05	0.12
Net Cash / Debt	-2.21	-2.71	-2.08	-1.68	-1.62	-1.22
Net Cash Per Share	-0.01	-0.02	-0.02	-0.07	-4.14	-3.63
Working Capital	-11.95	-11.71	-9.71	-8.06	-7.44	-5.74
Book Value Per Share	-0.05	-0.11	-0.11	-0.31	-19.05	-17.11

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.